Rapamycin for dogs requires a veterinary prescription, since it’s a prescription medication in the United States and most other countries. You cannot buy it over the counter or order it online without one. The most straightforward path is finding a veterinarian willing to prescribe it off-label for longevity purposes, though you may also be able to enroll your dog in an active clinical trial.
Getting a Prescription Through Your Vet
Rapamycin is FDA-approved for use in humans (as an immunosuppressant for organ transplant patients), but it has no veterinary approval. That means any vet who prescribes it for your dog is doing so off-label, which is legal but entirely at the veterinarian’s discretion. Many general-practice vets are unfamiliar with rapamycin’s use for canine longevity or simply uncomfortable prescribing it without more data. If your regular vet declines, that’s common, not a dead end.
Your best bet is seeking out a veterinarian who specializes in integrative medicine, longevity, or geriatric care. A growing number of vets now offer rapamycin as part of a longevity protocol, and some practices have built their reputation around it. You can search directories of integrative or holistic veterinary practitioners, or look for vets who explicitly mention rapamycin or anti-aging protocols on their websites. Telemedicine veterinary consultations have also made this more accessible; some longevity-focused vets will do remote consultations and write prescriptions that can be filled at a compounding pharmacy.
Once you have a prescription, it’s typically filled through a compounding pharmacy rather than a standard pharmacy. Compounding pharmacies can prepare rapamycin in dog-friendly doses and tablet sizes. The cost varies, but expect to pay roughly $50 to $150 per month depending on your dog’s size and the pharmacy.
The Dog Aging Project’s TRIAD Trial
The largest and most rigorous study of rapamycin in dogs is the Test of Rapamycin in Aging Dogs (TRIAD), run by the Dog Aging Project. This is a placebo-controlled, multi-site clinical trial that provides the drug (or placebo) for free, along with veterinary monitoring throughout. The catch: enrollment criteria are specific. The trial targets healthy, middle-aged dogs in defined weight ranges between 20 and 55 kg (roughly 44 to 121 pounds). Dogs with significant existing health conditions are excluded. If your dog qualifies, this is an excellent way to access rapamycin with built-in safety monitoring, though you won’t know whether your dog receives the drug or a placebo.
You can check the Dog Aging Project’s website for open enrollment periods and participating veterinary clinics near you.
How Rapamycin Works in Dogs
Rapamycin targets a protein called mTOR, which acts as a central control switch for cell growth and metabolism. When nutrients and energy are abundant, mTOR ramps up cell growth and protein production while dialing down the body’s cellular recycling process (autophagy). This is useful during development but becomes a liability with age: overactive mTOR signaling accelerates wear and tear on cells that aren’t being cleaned up efficiently.
By partially inhibiting mTOR, rapamycin essentially tells cells to slow down on growth and spend more energy on maintenance. Cells recycle damaged components more effectively, produce fewer faulty proteins, and generally behave more like younger cells. This pathway is highly conserved across mammals, meaning it works the same way in dogs as it does in mice and humans. In laboratory animals, mTOR inhibition consistently extends lifespan and delays age-related diseases.
What the Evidence Shows So Far
The honest picture: rapamycin’s benefits in dogs are promising but not yet proven by large-scale trials. In a small, placebo-controlled study of 17 healthy pet dogs, low-dose rapamycin was well tolerated with no clinically significant adverse events. The researchers looked specifically at heart function and found an improvement in one measure of how effectively the heart pumps (left ventricular fractional shortening), though the overall cardiac results were modest.
The TRIAD trial, which is much larger and longer, administers rapamycin at 0.15 mg/kg once weekly for a full year. It’s designed to answer the bigger questions about whether rapamycin meaningfully improves healthspan in companion dogs. Results from this trial will carry far more weight than the smaller studies completed so far. Until then, you’re making a decision based on strong animal-model evidence and limited but reassuring dog-specific safety data.
Dosing and How It’s Given
The dose used in the TRIAD trial, and widely referenced by longevity-focused vets, is 0.15 mg/kg given by mouth once per week. For a 30 kg (66-pound) dog, that works out to roughly 4.5 mg per week in a single dose. The drug comes in small tablets and can be given with or without food, on whatever day you choose, though consistency matters.
Once-weekly dosing is a deliberate choice. At this frequency, rapamycin primarily inhibits one branch of the mTOR system (mTORC1, the one linked to longevity benefits) while largely sparing the other branch (mTORC2, which is associated with unwanted metabolic side effects). Weekly dosing also avoids the immune suppression seen at the much higher daily doses used in transplant medicine. The low doses used for longevity are not considered immunosuppressive.
Safety and Side Effects
At longevity-level doses, rapamycin has a reassuring safety profile in dogs so far. In clinical trials, no significant adverse events were reported. The drug has been tolerated at doses up to 1 mg/kg per day for as long as 14 months, which is roughly seven times the weekly longevity dose given daily.
In rodent studies, higher doses have been linked to elevated blood lipids, cataracts, changes in blood sugar regulation, and reproductive effects. In elderly humans taking similar low-dose regimens, the most common side effects are mild and temporary: mouth sores, loose stools, and mildly elevated cholesterol. These same side effects are theoretically possible in dogs, though they haven’t appeared at notable rates in the studies completed to date.
Most vets prescribing rapamycin will want baseline blood work before starting, including a complete blood count and chemistry panel to check liver and kidney function, blood sugar, and cholesterol. Periodic rechecks every three to six months are typical. If your dog develops any gastrointestinal symptoms, mouth sores, or seems lethargic, your vet may adjust the dose or pause treatment.
What to Expect Practically
If you go the prescription route, the process generally looks like this: an initial consultation (in-person or telemedicine) where the vet reviews your dog’s health history, age, weight, and breed. They’ll order blood work to establish a baseline. Assuming everything looks normal, they’ll write a prescription for a compounding pharmacy to fill. You’ll give your dog one small tablet per week at home and return for follow-up blood work on a schedule your vet sets.
You won’t see dramatic overnight changes. The premise of rapamycin is slowing the trajectory of aging, not reversing visible symptoms. Some owners report subjective improvements in energy or mobility after a few months, but these are anecdotal. The real measure of success is what happens over years, which is exactly what the TRIAD trial is designed to capture.
Dogs that are very young, very small (under 20 kg), or already dealing with serious illness like cancer or organ failure are generally not good candidates. Rapamycin is best suited for healthy, middle-aged to older dogs where the goal is extending the healthy years ahead.